271 related articles for article (PubMed ID: 17848153)
1. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer.
Rajkovaca Z; Vuleta G; Matavulj A; Kovacević P; Ponorac N
Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153
[TBL] [Abstract][Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
3. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
4. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
5. Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancer.
Cwikla JB; Buscombe JR; Parbhoo SP; Kelleher SM; Thakrar DS; Hinton J; Crow J; Deery A; Hilson AJ
Nucl Med Commun; 1998 Jul; 19(7):649-55. PubMed ID: 9853345
[TBL] [Abstract][Full Text] [Related]
6. Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer.
Usmani S; Niaz K; Maseeh-Uz-Zaman ; Kamal S; Niyaz K; Mehboob J; Hashmi A; Habib S; Hashmi H
J Pak Med Assoc; 2007 Apr; 57(4):172-5. PubMed ID: 17489522
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m MIBI in suspected recurrent breast cancer.
Cwikla JB; Kolasinska A; Buscombe JR; Hilson AJ
Cancer Biother Radiopharm; 2000 Aug; 15(4):367-72. PubMed ID: 11041021
[TBL] [Abstract][Full Text] [Related]
8. International prospective evaluation of scintimammography with (99m)technetium sestamibi.
Sampalis FS; Denis R; Picard D; Fleiszer D; Martin G; Nassif E; Sampalis JS
Am J Surg; 2003 Jun; 185(6):544-9. PubMed ID: 12781883
[TBL] [Abstract][Full Text] [Related]
9. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
11. The initial Australian experience of technetium-99M sestamibi scintimammography: a complementary test in the management of breast cancer.
Sillar R; Howarth D; Clark D
Aust N Z J Surg; 1997 Jul; 67(7):433-7. PubMed ID: 9236609
[TBL] [Abstract][Full Text] [Related]
12. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ
Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
[TBL] [Abstract][Full Text] [Related]
13. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
15. Sestamibi scintimammography in pT1 breast cancer: alternative or complementary to X-ray mammography?
Lumachi F; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Geatti O; Bui F; Brandes AA
Anticancer Res; 2001; 21(3C):2201-5. PubMed ID: 11501847
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer.
Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A
Breast J; 2003; 9(4):288-94. PubMed ID: 12846862
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
[TBL] [Abstract][Full Text] [Related]
18. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
20. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
